A study of 42,000 abortions found that women suffered four times as many adverse side effects from this two-step regimen than surgical abortion. One in five abortions induced by mifepristone resulted in negative health outcomes, the study found. Due to this record, the federal government had required the mifepristone to be distributed only by certain authorized health centers or online distributors.
But on Tuesday, the Biden administration’s FDA changed the legal regulations to allow retail pharmacies that become certified to distribute the pill through the first 10 weeks of gestation (“although many clinics and telemedicine providers have begun offering it up to 12 or 13 weeks into pregnancy,” reported The New York Times). The protocols also require pharmacies to keep the name of the abortionist who prescribed the pill a secret even from other branches of that pharmacy, according to the Times.
Retail pharmacy giants CVS and Walgreens immediately confirmed they plan to complete the certification process and carry the abortion-inducing pill.
Join the conversation as a VIP Member